39 results on '"Dostalova Merkerova, Michaela"'
Search Results
2. Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1
3. Rapid and sensitive detection of multiple microRNAs in cell lysate by low-fouling surface plasmon resonance biosensor
4. Aging-Related Gene Expression Signatures Define Likelihood of Disease Progression in Patients with Lower-Risk Myelodysplastic Syndromes
5. Upregulation of ZEB1-Derived Circular RNAs Is Associated with SF3B1-Mutated Myelodysplastic Neoplasms
6. Differential expression of homologous recombination DNA repair genes in the early and advanced stages of myelodysplastic syndrome
7. Changes Associated With Lenalidomide Treatment in the Gene Expression Profiles of Patients With Del(5q)
8. Circular RNAs in Myelodysplastic Syndromes and Impact of SF3B1 Mutations on Their Expression
9. Different Mutations in SF3B1 Gene Have Specific Transcriptomic Characteristics in Myelodysplastic Neoplasms
10. Accelerated Progression in Lower-Risk Myelodysplastic Neoplasms: Attenuated Cell Cycle, DNA Damage Response, and Augmented Oncogenic Transcriptome Signatures
11. Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34+ Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients
12. Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients
13. Deregulation of Gene Expression Induced by Environmental Tobacco Smoke Exposure in Pregnancy
14. LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome
15. Circular RNAs in Hematopoiesis with a Focus on Acute Myeloid Leukemia and Myelodysplastic Syndrome
16. Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome
17. Molecular Fingerprints of Borderline Changes in Kidney Allografts Are Influenced by Donor Category
18. RUNX1 Mutation Accompanied with Dysregulated Cellular Senescence in Lower-Risk Myelodysplastic Syndrome Patients Is Associated with Disease Progression
19. Circulating Small Noncoding RNAs As Novel Semi-Invasive Markers of Patient Survival in Myelodysplastic Syndromes
20. Genetic Variant Screening of DNA Repair Genes in Myelodysplastic Syndrome Identifies a Novel Mutation in the XRCC2 Gene
21. Differential Expression of MicroRNAs in CD34+ Cells of 5q- Syndrome
22. RUNX1mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS
23. Mutations in RUNX1 and TP53 Genes Predict Progression in Patients with Lower-Risk Myelodysplastic Syndrome
24. Relationship between Altered Gene Expression and DNA Methylation of the DLK1-DIO3 region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes
25. Deregulated Expression of Long Noncoding RNAs H19, LEF1-AS1, TCL6, and WT1-AS1 Predicts Poor Outcome of Patients with Myelodysplastic Syndromes
26. Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment
27. Different Mutations in SF3B1Gene Have Specific Transcriptomic Characteristics in Myelodysplastic Neoplasms
28. Changes in Gene Expression Profiles in Patients with 5q- Syndrome Caused by Lenalidomide Treatment
29. Differential Expression of MicroRNAs in CD34+ Cells of 5q- Syndrome
30. Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome
31. Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome.
32. Transposable elements and Piwi-interacting RNAs in hemato-oncology with a focus on myelodysplastic syndrome.
33. Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34 + Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients.
34. Circular RNAs in Myelodysplastic Syndromes and Impact of SF3B1Mutations on Their Expression
35. RUNX1Mutation Accompanied with Dysregulated Cellular Senescence in Lower-Risk Myelodysplastic Syndrome Patients Is Associated with Disease Progression
36. Mutations in RUNX1and TP53Genes Predict Progression in Patients with Lower-Risk Myelodysplastic Syndrome
37. Deregulated Expression of Long Noncoding RNAs H19, LEF1-AS1, TCL6,and WT1-AS1Predicts Poor Outcome of Patients with Myelodysplastic Syndromes
38. Relationship between Altered Gene Expression and DNA Methylation of the DLK1-DIO3region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes
39. Recurrent chromosomal breakpoints in patients with myelodysplastic syndromes and complex karyotype versus fragile sites.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.